Ryan O'Hare
-
Pharma company acquires startup Oculeve for $125m (USD), including a novel nasal device for dry eye disease
-
The number of sight tests carried out in England fell by almost 23,000 in 2014–15, compared with the previous year
-
The National Institute for Health and Care Excellence has recommended aflibercept and a dexamethasone implant for diabetic macular oedema
-
A membership organisation for private ophthalmologists has been fined for breaches to competition law, including price setting
-
Key points for business and health to emerge from summer budget last week (8 July)
-
New data show median age climbs to 40-years-old as UK population hits 64.6 million people
-
New market report predicts growth will be driven by the launch of a number of new drugs and fixed-dose combinations
-
Chancellor announces departmental cuts which will claw back £200m in ‘non-NHS’ savings from the health budget and over £450m from higher and further education
-
Oraya Therapeutics has received a CE extension for its IRay Radiotherapy treatment for eye cancer patients in the UK, Germany and Switzerland
-
Ophthalmologists in the UK are ‘leading adopters’ of Oraya Therapy for treating patients with wet AMD